Heparin Market (Updated Version Available)

The report offers detailed coverage of Heparin industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Heparin by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.

Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.

The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.

Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%

Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.

Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.


The report forecast global Heparin market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Heparin market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio


At the same time, we classify Heparin according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Heparin Sodium
Heparin Calcium
Other
Market by Application
UFH
LMWH

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Heparin market for the forecast period 2021 - 2025?
• What are the driving forces in the Heparin market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Heparin industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?